Kentucky
General Assembly

02/13/25	introduced in House to Committee on Committees (H)
02/21/25	to Health Services (H)
02/27/25	reported favorably, 1st reading, to Calendar
02/28/25	2nd reading, to Rules posted for passage in the Regular Orders of the Day for Tuesday, March 04, 2025
03/04/25	floor amendment (1) filed
03/05/25	3rd reading, passed 97-0 with Floor Amendment (1)
03/06/25	received in Senate to Committee on Committees (S)
03/11/25	to Health Services (S)
03/12/25	reported favorably, 1st reading, to Calendar
03/13/25	2nd reading, to Rules
03/27/25	floor amendments (1-title) and (2) filed
03/28/25	posted for passage in the Regular Orders of the Day for Friday, March 28, 2025 3rd reading, passed 38-0 with Floor Amendment (2) and Floor Amendment (1-title) received in House to Rules (H) posted for passage for concurrence in Senate Floor Amendment (2) and Floor Amendment (1-title) House concurred in Senate Floor Amendment (2) and Floor Amendment (1-title) passed 83-16 enrolled, signed by Speaker of the House enrolled, signed by President of the Senate delivered to Governor
04/01/25	filed without Governor's signature with the Secretary of State
04/10/25	became law without Governor's Signature (Acts Ch. 161)

Amendment	House Floor Amendment 1
Sponsor	M. Whitaker
Summary	Establish requirements for pharmacists dispensing prescriptions in the event of a practitioner's death.
Index Headings	Deaths - Prescription drug dispensing, deceased practitioners, requirements Drugs and Medicines - Prescription drug dispensing, pharmacists, requirement Health and Medical Services - Prescription drug dispensing, pharmacists, requirement Pharmacists - Prescription drug dispensing, practitioners, requirement Physicians and Practitioners - Prescription drug dispensing, pharmacists, requirement

Amendment	Senate Floor Amendment 1
Sponsor	R. Mills
Summary	Make title amendment.
Index Headings	Title Amendments - HB 501/GA

Amendment	Senate Floor Amendment 2
Sponsor	R. Mills
Summary	Amend RS 2025 HB 495/VO Section 1 to limit the prohibition on Medicaid expenditures for cross-sex hormones to instances of the cross-sex hormones being prescribed or administered primarily or solely for the treatment of gender dysphoria.
Index Headings	Drugs and Medicines - Medicaid, coverage, cross-sex hormones Public Assistance - Medicaid, coverage, cross-sex hormones Public Medical Assistance - Medicaid, coverage, cross-sex hormones Medicaid - Coverage, cross-sex hormones